Cardiac synchronization and arrhythmia during irreversible electroporation
- PMID: 32483842
- DOI: 10.1002/jso.26041
Cardiac synchronization and arrhythmia during irreversible electroporation
Abstract
Background and objectives: Irreversible electroporation (IRE) is a nonthermal electrical tumor ablative strategy for unresectable tumors. IRE is relatively safe around critical structures but may induce cardiac arrhythmia when its delivery is not synchronized to the cardiac cycle. We performed a systematic literature review to determine rates of arrhythmia when IRE was utilized with or without cardiac synchronization.
Methods: An online literature search was conducted with additional hand selection of articles. Data were extracted and pooled analyses were performed.
Results: Twelve articles were included in analysis. IRE was performed for 481 patients; 46% hepatic tumors (n = 223), 36% pancreatic lesions (n = 168), and multiple other locations including prostate. Synchronization was performed on 422 patients. Arrhythmias were noted in 3.7% of cases (n = 18/481); cardiac synchronization: 1.2% (n = 5/422) vs unsynchronized: 22.0% (n = 13/59), P < .0001. These events occurred in every organ except the prostate.
Conclusions: IRE remains a potent technology for unresectable tumors, but arrhythmia is a clinical concern. This literature review confirms that cardiac gating should be used in all cases outside of prostate to prevent this potentially serious adverse event.
Keywords: arrhythmia; cardiac complications; irreversible electroporation; tumor ablation.
© 2020 Wiley Periodicals LLC.
References
REFERENCES
-
- Davalos RV, Mir IL, Rubinsky B. Tissue ablation with irreversible electroporation. Ann Biomed Eng. 2005;33(2):223-231.
-
- Charpentier KP, Wolf F, Noble L, Winn B, Resnick M, Dupuy DE. Irreversible electroporation of the pancreas in swine: a pilot study. HPB (Oxford). 2010;12(5):348-351.
-
- Bower M, Sherwood L, Li Y, Martin R. Irreversible electroporation of the pancreas: definitive local therapy without systemic effects. J Surg Oncol. 2011;104(1):22-28.
-
- Latouche EL DR, Martin RCG II. Modeling of irreversible electroporation treatments for the optimization of pancreatic cancer therapies. New York, NY: Springer International Publishing; 2015.
-
- Bhutiani N, Doughtie CA, Martin RC 2nd. Ultrasound validation of mathematically modeled irreversible electroporation ablation areas. Surgery. 2016;159(4):1032-1040.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical